Press Releases
Complete Genomics is making headlines. Read the most recent news about Complete Genomics and advances in complete human genome sequencing.
Complete Genomics Publishes Paper Describing Its Informatics Approach for High-Accuracy Whole Human Genome Sequencing
Jan 19, 2012
Complete Genomics Inc. (NASDAQ: GNOM) announced today that the Journal of Computational Biology has published online the company’s paper describing some of the computational methods that enable it to produce highly-accurate whole human genome sequencing data.
>> read moreComplete Genomics Announces Shipment of Approximately 3,000 Genomes in 2011
Jan 9, 2012
Complete Genomics, Inc. (Nasdaq: GNOM), today announced that the company delivered approximately 3,000 genomes to its customers in 2011 and is entering 2012 with contracts for approximately 5,800 genomes.
>> read moreComplete Genomics to Present at Oppenheimer Healthcare Conference
Dec 9, 2011
Complete Genomics (NASDAQ: GNOM) today announced that Ajay Bansal, Chief Financial Officer of Complete Genomics will present at the Oppenheimer 22nd Annual Healthcare Conference at 11:25 a.m. ET on Wednesday, December 14, 2011.
>> read moreComplete Genomics Reports Results for Third Quarter 2011
Nov 8, 2011
Complete Genomics, Inc. (Nasdaq: GNOM), the whole human genome sequencing company, today announced its financial results for the quarter ended September 30, 2011.
>> read moreComplete Genomics Schedules Third Quarter 2011 Earnings Release and Announces Conference Call
Nov 3, 2011
Complete Genomics, Inc. (Nasdaq: GNOM) will release its third quarter 2011 financial results after markets close on November 7, 2011.
>> read moreComplete Genomics to Present at Upcoming Investor Conferences
Nov 3, 2011
Complete Genomics (NASDAQ: GNOM) today announced that Dr. Cliff Reid, chairman, president, and CEO of Complete Genomics will present at the following conferences in November
>> read moreComplete Genomics Launches Comprehensive Cancer Sequencing Service at ICHG/ASHG 2011
Nov 3, 2011
Complete Genomics Inc. (NASDAQ: GNOM), the whole human genome sequencing company, introduced its new Cancer Sequencing Service today at the International Congress of Human Genetics (ICHG) and American Society of Human Genetics (ASHG) Annual Meeting in Montréal.
>> read moreScripps Health and Complete Genomics Announce Collaboration Aimed at Unlocking Genetic Secrets of Healthy Aging
Oct 3, 2011
Complete Genomics Inc. (NASDAQ: GNOM), the whole human genome sequencing company, and the not-for-profit Scripps Health system today announced a major collaboration that will help further the Wellderly Study, a landmark scientific research initiative aimed at unlocking the genetic secrets of lifelong health.
>> read moreComplete Genomics Partners With Inova Health System to Sequence the Genomes of 500 Babies and Their Parents
Sep 8, 2011
MOUNTAIN VIEW, Calif., and FALLS CHURCH, Va. – Complete Genomics Inc. (NASDAQ: GNOM), a complete human genome sequencing company, and Inova Health System, a not-for-profit healthcare system based in Northern Virginia, today announced additional details about their partnership.
>> read moreComplete Genomics to Present at Three Upcoming Investor Conferences
Sep 1, 2011
Complete Genomics (NASDAQ: GNOM) today announced that members of its management team will present at the following conferences in September
>> read moreComplete Genomics Appoints Chief Commercial Officer and Chief Medical Officer
Aug 25, 2011
Complete Genomics Inc. (NASDAQ: GNOM), the complete human genome sequencing company, today announced it has appointed Keith Raffel as chief commercial officer (CCO) and Dr. Jill Hagenkord as chief medical officer (CMO).
>> read moreComplete Genomics to Sequence More Than 1,000 Additional Genomes for National Cancer Institute’s Pediatric Cancer Study
Aug 24, 2011
Complete Genomics Inc. (NASDAQ: GNOM), the complete human genome sequencing company, today announced additional details about the option that SAIC-Frederick Inc. has exercised to have Complete Genomics sequence the DNA from more than 500 pediatric cancer cases.
>> read moreComplete Genomics Reports Results for Second Quarter 2011
Aug 3, 2011
Complete Genomics, Inc. (Nasdaq: GNOM) today announced its financial results for the quarter ended June 30, 2011.
>> read moreComplete Genomics Schedules Second Quarter 2011 Earnings Release and Announces Conference Call
Aug 1, 2011
Complete Genomics, Inc. (Nasdaq: GNOM) will release its second quarter 2011 financial results after markets close on Wednesday August 3, 2011.
>> read moreComplete Genomics Launches Cancer Grant Program
Jun 29, 2011
Complete Genomics Inc. (NASDAQ: GNOM), a complete human genome sequencing company, today announced that it is introducing a new cancer grant program.
>> read moreComplete Genomics to Present at Three Upcoming Investor Conferences
Jun 2, 2011
Complete Genomics (NASDAQ: GNOM) today announced that members of its management team will present at the following conferences in June
>> read moreComplete Genomics Announces Closing of Public Offering and Exercise of Over-Allotment Option
Jun 1, 2011
Complete Genomics, Inc. (Nasdaq: GNOM) announced the closing of its underwritten public offering of 6,325,000 shares of its common stock at $12.50 per share.
>> read moreComplete Genomics Announces Pricing of Public Offering
May 26, 2011
Complete Genomics, Inc. (Nasdaq: GNOM) announced the pricing of its underwritten public offering of 5,500,000 shares of its common stock at $12.50 per share. Complete Genomics has granted the underwriters a 30-day option to purchase up to 825,000 additional shares
>> read moreErasmus University Medical Center Partners With Complete Genomics to Begin Developing Its Genomic Medicine Pipeline
May 18, 2011
Complete Genomics Inc. (NASDAQ: GNOM), a complete human genome sequencing company that has developed and commercialized an innovative DNA sequencing platform, announced today an expansion of its collaboration with Erasmus University Medical Center.
>> read moreComplete Genomics Files Registration Statement for Proposed Offering of Common Stock
May 10, 2011
Complete Genomics, Inc. (Nasdaq: GNOM) today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to the underwritten public offering of 4,500,000 shares of its common stock, or up to 5,175,000 shares if the underwriters exercise their over-allotment option.
>> read moreComplete Genomics Reports Results for First Quarter 2011
May 9, 2011
Complete Genomics, Inc. (Nasdaq: GNOM) today announced its financial results for the quarter ended March 31, 2011.
>> read moreComplete Genomics Schedules First Quarter 2011 Earnings Release and Announces Conference Call
May 5, 2011
Complete Genomics, Inc. (Nasdaq: GNOM) will release its first quarter 2011 financial results following the close of market on Monday, May 9, 2011.
>> read moreComplete Genomics to Present at BioCentury Future Leaders in the Biotech Industry Conference
Apr 7, 2011
Complete Genomics (NASDAQ: GNOM) will present at the BioCentury Future Leaders in the Biotech Industry Conference on Friday, April 15, 2011.
>> read moreComplete Genomics Adds 29 High-Coverage, Complete Human Genome Sequencing Datasets to its Public Genomic Repository
Apr 6, 2011
Complete Genomics Inc. (NASDAQ: GNOM), a complete human genome sequencing company that has developed and commercialized an innovative DNA sequencing platform, announced today that it has added 29 high-coverage, complete human genome sequences to its public genomic repository.
>> read moreComplete Genomics Customers Can Now Use DNAnexus’ Cloud-Based Informatics Solution to Study Their Human Genome Sequencing Data
Mar 14, 2011
MOUNTAIN VIEW, Calif., and PALO ALTO, Calif. — Complete Genomics Inc. (NASDAQ: GNOM) announced today that its customers can now choose to store and visualize their human genome sequencing data within the cloud-based DNAnexus platform.
>> read moreComplete Genomics to Present at the Barclays Capital Global Healthcare Conference
Mar 10, 2011
Complete Genomics (Nasdaq:GNOM) will present at the Barclays Capital Global Healthcare Conference on Thursday, March 17, 2011.
>> read moreComplete Genomics Reports Results for Fourth Quarter and Fiscal Year 2010
Mar 10, 2011
Complete Genomics, Inc. (Nasdaq:GNOM) today announced its financial results for the quarter and fiscal year ended December 31, 2010.
>> read moreComplete Genomics to Announce Fourth-Quarter and Fiscal Year 2010 Results
Mar 8, 2011
Complete Genomics, Inc. (Nasdaq:GNOM) will announce its fourth-quarter and fiscal year 2010 financial results following the close of market on Thursday, March 10, 2011.
>> read moreComplete Genomics to Present at the Cowen and Company Health Care Conference
Feb 24, 2011
Complete Genomics (NASDAQ: GNOM) will present at the Cowen and Company 31st Annual Health Care Conference on Tuesday, March 8, 2011.
>> read moreComplete Genomics Selected by MIT’s Technology Review for Top 50 Innovative Companies List
Feb 21, 2011
Complete Genomics Inc. (NASDAQ: GNOM) announced today that it has been selected by MIT’s Technology Review to be included in the 2011 TR50, its annual list of the 50 most innovative companies in the world.
>> read more